AR029984A1 - Metodo para reducir las exacerbaciones asociadas copd ambito - Google Patents

Metodo para reducir las exacerbaciones asociadas copd ambito

Info

Publication number
AR029984A1
AR029984A1 ARP010103546A ARP010103546A AR029984A1 AR 029984 A1 AR029984 A1 AR 029984A1 AR P010103546 A ARP010103546 A AR P010103546A AR P010103546 A ARP010103546 A AR P010103546A AR 029984 A1 AR029984 A1 AR 029984A1
Authority
AR
Argentina
Prior art keywords
copd
excerbations
ambito
reducing associated
reducing
Prior art date
Application number
ARP010103546A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR029984A1 publication Critical patent/AR029984A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP010103546A 2000-07-27 2001-07-25 Metodo para reducir las exacerbaciones asociadas copd ambito AR029984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27

Publications (1)

Publication Number Publication Date
AR029984A1 true AR029984A1 (es) 2003-07-23

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103546A AR029984A1 (es) 2000-07-27 2001-07-25 Metodo para reducir las exacerbaciones asociadas copd ambito

Country Status (16)

Country Link
EP (1) EP1320361A4 (de)
JP (1) JP2004505039A (de)
KR (1) KR20030019620A (de)
CN (1) CN1444476A (de)
AR (1) AR029984A1 (de)
AU (2) AU7902301A (de)
BR (1) BR0112682A (de)
CA (1) CA2417336A1 (de)
CZ (1) CZ2003141A3 (de)
HU (1) HUP0300685A3 (de)
IL (1) IL153919A0 (de)
MX (1) MXPA03000714A (de)
NO (1) NO20030332D0 (de)
PL (1) PL365612A1 (de)
WO (1) WO2002009689A1 (de)
ZA (1) ZA200300476B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
KR102087661B1 (ko) * 2018-07-27 2020-03-11 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
AU772909B2 (en) * 1999-10-29 2004-05-13 Smithkline Beecham Corporation Method for administering a phosphodiesterase 4 inhibitor

Also Published As

Publication number Publication date
AU7902301A (en) 2002-02-13
BR0112682A (pt) 2003-06-24
WO2002009689A1 (en) 2002-02-07
AU2001279023B2 (en) 2005-11-10
ZA200300476B (en) 2004-04-23
CN1444476A (zh) 2003-09-24
NO20030332L (no) 2003-01-22
EP1320361A1 (de) 2003-06-25
MXPA03000714A (es) 2003-06-04
EP1320361A4 (de) 2006-04-05
IL153919A0 (en) 2003-07-31
JP2004505039A (ja) 2004-02-19
PL365612A1 (en) 2005-01-10
CA2417336A1 (en) 2002-02-07
CZ2003141A3 (cs) 2004-07-14
HUP0300685A3 (en) 2004-10-28
KR20030019620A (ko) 2003-03-06
NO20030332D0 (no) 2003-01-22
HUP0300685A2 (hu) 2003-12-29

Similar Documents

Publication Publication Date Title
NO20042080L (no) Inhibitorer for post-prolin spaltningsproteaser
ECSP034519A (es) Inhibidores de xantina fosfodiesterasa v
NO20035603D0 (no) Fluorpyrrolidiner som dipeptidyl peptidase inhibitorer
AR029984A1 (es) Metodo para reducir las exacerbaciones asociadas copd ambito
DK1242415T3 (da) 3-thiazol-4-yl-pyrolidinderivater som AMP-specifikke phosphodiesteraseinhibitorer
CA2457944A1 (en) Polycyclic guanine phosphodiesterase v inhibitors
BR0317139A (pt) Métodos e compostos para produção de inibidores de dipeptidil peptidase iv e seus intermediários
UY26942A1 (es) N-acilsulfonamidas promotoras de la apoptosis
BR0317715A (pt) Composições e processos de uso de collajolie
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
HK1070008A1 (en) Combination of cytochome p 450 dependent protease inhibitors
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
AP2001002205A0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase.
DK0792643T3 (da) Anvendelse af en aldosereduktaseinhibitor til at reducere skade på ikke-cardialt væv
WO2002060869A3 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
WO2001056573A8 (en) Use of cox-2 inhibitors as gastroprokinetics
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
BR0213126A (pt) Compostos heterocìclicos insaturados de 6 membros úteis para inibição seletiva da cascata de coagulação
AP2001002248A0 (en) Method for treating COPD.
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
DE602004007409D1 (de) Verfahren zum Verbinden mindestens zweier Glieder
BR0009453B1 (pt) processo para a preparação de um composto.
AU2002367752A8 (en) Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
ATE274599T1 (de) Verfahren zur enzymatischen racematspaltung von aminomethyl-aryl-cyclohexanol-derivaten
FI20010472A (fi) Menetelmä alfa-pineenin hydraamiseksi

Legal Events

Date Code Title Description
FA Abandonment or withdrawal